To date, increased PCSK9 levels and its impact on dyslipidema has been reported in the most common autoimmune disease in childhood, T1DM (118), and future studies in pediatric Hashimoto thyroiditis are warranted. Here, PCSK9 is linked to type 1 diabetes mellitus.